Junkosha names new US leadership

Joe Rowan is retiring as CEO and president of Junkosha USA. [Photo courtesy of Junkosha]

Japanese fluoropolymer supplier Junkosha today announced new leadership for its U.S. subsidiary.

Joe Rowan has retired as CEO and president of Junkosha USA but will remain as an advisor as Mike Winterling takes over as chief operating officer.

“Our aim is to be acknowledged as the most responsive partner for specialized high-performance polymer solutions; to be organizations’ No. 1 partner by meeting their unmet needs and ultimately being easy to do business with,” Junkosha CEO and President Mamoru Sogo said in a news release. “This is what we have always strived to do and will further expand our global presence into the future with Mike as he takes over from Joe as part of our succession plan.”

Rowan founded Irvine, California-based Junkosha USA, which sells fluoropolymer-based medical components …

Read more
  • 0

Medtronic enrolls first patient in head-to-head aortic stent graft trial with Gore Medical

Left: the Endurant II. Right: the Excluder AAA. [Images from the websites of Medtronic and Gore]Medtronic (NYSE:MDT) today announced that it enrolled the first patient in a head-to-head trial of aortic stent graft systems.

The Advance trial evaluates the Medtronic Endurant II/IIs and the Gore Excluder AAA device family.

Medtronic said in a news release that it expects to enroll 550 patients at up to 50 global centers in the trial. After that, the plan is to randomize patients to receive endovascular aneurysm repair (EVAR). The EVAR would come from either the Endurant or Excluder families of grafts. Follow-up comes at one month, one year and annually throughout five years.

Dr. Ray Workman and his team at Novant Health Forsyth Medical Center (Winston-Salem, North Carolina) enrolled the first patient.

“Through the Advance trial, we are working to deepen our evidence of sac regression as a key indicator of long-term EVAR patient…

Read more
  • 0